BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Hamas Navy head, engineer of Khan Yunis tunnel network killed in Gaza, IDF confirms - 2In these U.S. groups, deaths now exceed births. What’s happening?
- 3Oldest evidence of human fire-making discovered at site in England
- 4The most effective method to Execute a Lung-Solid Eating routine After a Cellular breakdown in the lungs Finding
- 5Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
- AI’s errors may be impossible to eliminate – what that means for its use in health care
- See the famous winged horse Pegasus fly in the autumn night sky
- 'Heated Rivalry' is just the tip of the iceberg. How hockey became the sexiest sport
- 4 astronauts are en route home from ISS after medical issue forces early exit
- Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
- 5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- Israeli archaeologists launch project to trace origins of ancient pottery
- The Significance of Prenuptial Arrangements in Separation Procedures
- Flu is rising rapidly, driven by a new variant. Here's what to know
